Physician

Arpenik Avakian, M.D., PH.D.

According to 2025 Medicare claims, Arpenik Avakian, M.D., PH.D. (NPI: 1073627519) practices ophthalmology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is RETINA EYECARE, PLLC (NPI: 1306980966; TIN: 208026638) and primary practice location at 98026-7512.

Avakian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 7,206 HCPCS/CPT codes, and received $571,061 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 1,334 prescription claims across 374 beneficiaries totaling $21,173 in drug costs, led by Ciprofloxacin Hcl (Ciprofloxacin Hcl). Open Payments data shows 2 records totaling $49. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$286K$571K2015 Medicare payment: $544,630 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $534,913 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $535,226 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $566,717 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $568,838 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $533,265 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $552,607 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $483,920 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $547,394 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $571,061 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156489,094$544,630
20166689,274$534,913
20176888,956$535,226
20187209,736$566,717
20196898,427$568,838
20206187,159$533,265
20216417,139$552,607
20226356,853$483,920
20236488,183$547,394
20245927,206$571,061

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$39K2015 Drug cost: $38,674 (USD; Tot_Drug_Cst)2016 Drug cost: $30,657 (USD; Tot_Drug_Cst)2017 Drug cost: $34,713 (USD; Tot_Drug_Cst)2018 Drug cost: $34,914 (USD; Tot_Drug_Cst)2019 Drug cost: $34,001 (USD; Tot_Drug_Cst)2020 Drug cost: $37,978 (USD; Tot_Drug_Cst)2021 Drug cost: $33,068 (USD; Tot_Drug_Cst)2022 Drug cost: $28,006 (USD; Tot_Drug_Cst)2023 Drug cost: $31,977 (USD; Tot_Drug_Cst)2024 Drug cost: $21,173 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015252734$38,674
2016274797$30,657
2017288852$34,713
2018299881$34,914
2019310952$34,001
2020296965$37,978
20213281,017$33,068
20223471,084$28,006
20233601,192$31,977
20243741,334$21,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye332462$137
92014Established patient complete exam of visual system5391,182$102
92134Imaging of retina368711$33
92250Photography of the retina356508$29
92202Extended exam of the back part of the eye with optic nerve drawing395558$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ciprofloxacin HclCiprofloxacin Hcl5829,725$6,019
LatanoprostLatanoprost26612,036$3,111
Prednisolone AcetatePrednisolone Acetate772,051$2,403
OfloxacinOfloxacin982,033$1,219
MoxifloxacinMoxifloxacin Hcl21324$939

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$49Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arpenik Avakian, M.D., PH.D.?

Tedicare shows public-source Medicare data for Arpenik Avakian, M.D., PH.D. (NPI 1073627519), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arpenik Avakian, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arpenik Avakian, M.D., PH.D.?

Arpenik Avakian, M.D., PH.D. is linked to RETINA EYECARE, PLLC (billing NPI 1306980966) in the available physician profile data.

Does Arpenik Avakian, M.D., PH.D. have Open Payments data?

Arpenik Avakian, M.D., PH.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.